Dual HDAC and PI3K Inhibitor: A Novel Potential Therapeutic Option in Cushing Disease.

MedStar author(s):
Citation: Journal of Clinical Endocrinology & Metabolism. 106(2):e1036-e1038, 2021 01 23.PMID: 33205152Institution: MedStar Washington Hospital CenterDepartment: Medicine/EndocrinologyForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Phosphatidylinositol 3-Kinases | *Pituitary ACTH Hypersecretion | Histone Deacetylase Inhibitors/tu [Therapeutic Use] | Humans | Phosphoinositide-3 Kinase Inhibitors | Pituitary ACTH Hypersecretion/dt [Drug Therapy]Year: 2021Local holdings: Available online through MWHC library: 1999- June 2013, Available in print through MWHC library: 1999 - 2006ISSN:
  • 0021-972X
Name of journal: The Journal of clinical endocrinology and metabolismAll authors: Sharma STOriginally published: Journal of Clinical Endocrinology & Metabolism. 106(2):e1036-e1038, 2021 Jan 23.Fiscal year: FY2021Digital Object Identifier: Date added to catalog: 2021-02-17
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 33205152 Available 33205152

Available online through MWHC library: 1999- June 2013, Available in print through MWHC library: 1999 - 2006

English

Powered by Koha